-
2022
Cost-efficient approach for phenotyping cells in large cohorts and relating them with COPD clinical outcomes
Read MoreIn Canada, over 2 million people suffer from COPD, costing over $1.5 billion per year in direct expenditures. However, no existing therapy…
-
Xuekui Zhang
Primary Investigator
-
